Acetylcholine receptor–specific immunosuppressive therapy of experimental autoimmune myasthenia gravis and myasthenia gravis

Publisher： John Wiley & Sons Inc

E-ISSN： 1749-6632|1413|1|76-81

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1413, Iss.1, 2018-02, pp. : 76-81

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholine receptor antibody–mediated animal models of myasthenia gravis and the role of complement

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 136-142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serological and experimental studies in different forms of myasthenia gravis

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 143-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

A unique subphenotype of myasthenia gravis

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1412, Iss. 1, 2018-01 ,pp. : 14-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor–positive myasthenia gravis patients

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 154-162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Developing treatment guidelines for myasthenia gravis

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1412, Iss. 1, 2018-01 ,pp. : 95-101

John Wiley & Sons Inc

Access to resources Recommend Favorite